$51.44
0.92% day before yesterday
NYSE, Nov 28, 09:30 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$51.44
-15.04 22.62% 1M
-0.20 0.39% 6M
-1.95 3.65% YTD
-1.95 3.65% 1Y
+19.73 62.22% 3Y
-1.56 2.94% 5Y
-1.56 2.94% 10Y
-1.56 2.94% 20Y
NYSE, Closing price Fri, Nov 28 2025
+0.47 0.92%
ISIN
US26622P1075
Symbol
DOCS

New AI Insights on Doximity Insights AI Insights on Doximity

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$9.6b
Enterprise Value
$8.7b
Net debt
positive
Cash
$878.4m
Shares outstanding
188.1m
Valuation (TTM | estimate)
P/E
40.8 | 32.9
P/S
15.4 | 14.8
EV/Sales
14.0 | 13.5
EV/FCF
27.9
P/B
8.8
Financial Health
Equity Ratio
85.6%
Return on Equity
20.6%
ROCE
22.1%
ROIC
85.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$621.3m | $647.6m
EBITDA
$258.6m | $354.7m
EBIT
$246.8m | $345.6m
Net Income
$253.0m | $291.6m
Free Cash Flow
$312.1m
Growth (TTM | estimate)
Revenue
20.2% | 13.5%
EBITDA
21.9% | 47.3%
EBIT
22.2% | 50.2%
Net Income
45.3% | 30.7%
Free Cash Flow
43.6%
Margin (TTM | estimate)
Gross
90.2%
EBITDA
41.6% | 54.8%
EBIT
39.7%
Net
40.7% | 45.0%
Free Cash Flow
50.2%
More
EPS
$1.3
FCF per Share
$1.7
Short interest
3.9%
Employees
830
Rev per Employee
$690.0k
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Doximity forecast:

16x Buy
62%
8x Hold
31%
2x Sell
8%

Analyst Opinions

26 Analysts have issued a Doximity forecast:

Buy
62%
Hold
31%
Sell
8%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
621 621
20% 20%
100%
- Direct Costs 61 61
17% 17%
10%
560 560
21% 21%
90%
- Selling and Administrative Expenses 209 209
19% 19%
34%
- Research and Development Expense 104 104
21% 21%
17%
259 259
22% 22%
42%
- Depreciation and Amortization 12 12
15% 15%
2%
EBIT (Operating Income) EBIT 247 247
22% 22%
40%
Net Profit 253 253
45% 45%
41%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Neutral
24/7 Wall Street
7 days ago
CVNA last traded at $313.25 a share after finding support at $285.02, which was double-bottom support dating back to June 2025.
Neutral
Seeking Alpha
22 days ago
Doximity, Inc. ( DOCS ) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Chief Financial Officer Conference Call Participants Brian Peterson - Raymond James & Associates, Inc., Research Division Michael Cherny - Leerink Partners LLC, Research Division Allen Lutz - BofA Se...
Neutral
Business Wire
22 days ago
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. “Our platform continues to grow with new AI tools to save physicians' time,” said Jeff Tangney, co-founder and CEO of Doximity. “In Q2, a record 650,000 prescribers used our workflow tools to...
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 830
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today